Cargando…
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235017/ https://www.ncbi.nlm.nih.gov/pubmed/37263992 http://dx.doi.org/10.1038/s41467-023-38999-0 |
| _version_ | 1785052613242257408 |
|---|---|
| author | Chmielecki, Juliann Gray, Jhanelle E. Cheng, Ying Ohe, Yuichiro Imamura, Fumio Cho, Byoung Chul Lin, Meng-Chih Majem, Margarita Shah, Riyaz Rukazenkov, Yuri Todd, Alexander Markovets, Aleksandra Barrett, J. Carl Hartmaier, Ryan J. Ramalingam, Suresh S. |
| author_facet | Chmielecki, Juliann Gray, Jhanelle E. Cheng, Ying Ohe, Yuichiro Imamura, Fumio Cho, Byoung Chul Lin, Meng-Chih Majem, Margarita Shah, Riyaz Rukazenkov, Yuri Todd, Alexander Markovets, Aleksandra Barrett, J. Carl Hartmaier, Ryan J. Ramalingam, Suresh S. |
| author_sort | Chmielecki, Juliann |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10235017 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102350172023-06-03 Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer Chmielecki, Juliann Gray, Jhanelle E. Cheng, Ying Ohe, Yuichiro Imamura, Fumio Cho, Byoung Chul Lin, Meng-Chih Majem, Margarita Shah, Riyaz Rukazenkov, Yuri Todd, Alexander Markovets, Aleksandra Barrett, J. Carl Hartmaier, Ryan J. Ramalingam, Suresh S. Nat Commun Author Correction Nature Publishing Group UK 2023-06-01 /pmc/articles/PMC10235017/ /pubmed/37263992 http://dx.doi.org/10.1038/s41467-023-38999-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Chmielecki, Juliann Gray, Jhanelle E. Cheng, Ying Ohe, Yuichiro Imamura, Fumio Cho, Byoung Chul Lin, Meng-Chih Majem, Margarita Shah, Riyaz Rukazenkov, Yuri Todd, Alexander Markovets, Aleksandra Barrett, J. Carl Hartmaier, Ryan J. Ramalingam, Suresh S. Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer |
| title | Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer |
| title_full | Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer |
| title_fullStr | Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer |
| title_full_unstemmed | Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer |
| title_short | Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer |
| title_sort | author correction: candidate mechanisms of acquired resistance to first-line osimertinib in egfr-mutated advanced non-small cell lung cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235017/ https://www.ncbi.nlm.nih.gov/pubmed/37263992 http://dx.doi.org/10.1038/s41467-023-38999-0 |
| work_keys_str_mv | AT chmieleckijuliann authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT grayjhanellee authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT chengying authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT oheyuichiro authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT imamurafumio authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT chobyoungchul authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT linmengchih authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT majemmargarita authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT shahriyaz authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT rukazenkovyuri authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT toddalexander authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT markovetsaleksandra authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT barrettjcarl authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT hartmaierryanj authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer AT ramalingamsureshs authorcorrectioncandidatemechanismsofacquiredresistancetofirstlineosimertinibinegfrmutatedadvancednonsmallcelllungcancer |